Preparing for the US Biosecure Act - what does it mean for the pharma industry?
The US Biosecure Act was passed by the House of Representatives in September and seems likely to become law.
The US Biosecure Act was passed by the House of Representatives in September and seems likely to become law.
As cell therapies continue to advance, the need for better automated, large-scale manufacturing options increases.
This year’s Nobel prize in physiology or medicine has been awarded to Victor Ambros and Gary Ruvkun for their groundbreaking research on microRNA.